Cargando…

Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer Therapeutics

The epithelial-mesenchymal transition (EMT) is a complicated biological process in which cells with epithelial phenotype are transformed into mesenchymal cells with loss of cell polarity and cell–cell adhesion and gain of the ability to migrate. EMT and the reverse mesenchymal-epithelial transitions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ling, Zheng, Jinxia, Oltean, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671305/ https://www.ncbi.nlm.nih.gov/pubmed/38002944 http://dx.doi.org/10.3390/genes14112001

Ejemplares similares

A repositioning screen using an FGFR2 splicing reporter reveals compounds that regulate epithelial-mesenchymal transitions and inhibit growth of prostate cancer xenografts
por: Li, Ling, et al.
Publicado: (2022)

Alternative Splicing in Angiogenesis
por: Bowler, Elizabeth, et al.
Publicado: (2019)

Identification of a comprehensive alternative splicing function during epithelial-mesenchymal transition
por: Qiu, Yushan, et al.
Publicado: (2023)

Pharmacology of Modulators of Alternative Splicing
por: Bates, David O., et al.
Publicado: (2017)

Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing
por: Stevens, Megan, et al.
Publicado: (2019)

Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo
por: Oltean, Sebastian, et al.
Publicado: (2008)

Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease
por: Stevens, Megan, et al.
Publicado: (2018)

Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds
por: Samatov, Timur R, et al.
Publicado: (2013)

PRKCSH Alternative Splicing Involves in Silica-Induced Expression of Epithelial–Mesenchymal Transition Markers and Cell Proliferation
por: Huang, Ruixue, et al.
Publicado: (2020)

Comprehensive Analysis of Alternative Splicing in Gastric Cancer Identifies Epithelial–Mesenchymal Transition Subtypes Associated with Survival
por: Jun, Yukyung, et al.
Publicado: (2022)

Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition
por: Ranieri, Danilo, et al.
Publicado: (2015)

DEAD-Box Helicase 27 Triggers Epithelial to Mesenchymal Transition by Regulating Alternative Splicing of Lipoma-Preferred Partner in Gastric Cancer Metastasis
por: Jin, Yirong, et al.
Publicado: (2022)

Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis
por: Stevens, Megan, et al.
Publicado: (2019)

SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing
por: Mavrou, Athina, et al.
Publicado: (2016)

Bleomycin-enhanced alternative splicing of fibroblast growth factor receptor 2 induces epithelial to mesenchymal transition in lung fibrosis
por: Chen, Kui-Jun, et al.
Publicado: (2018)

Alternative Splicing Regulated by Butyrate in Bovine Epithelial Cells
por: Wu, Sitao, et al.
Publicado: (2012)

Anti-Cancer Potential of Phytochemicals: The Regulation of the Epithelial-Mesenchymal Transition
por: Liu, Shuangyu, et al.
Publicado: (2023)

Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease
por: Ren, Pingping, et al.
Publicado: (2021)

FAK regulates epithelial-mesenchymal transition in adenomyosis
por: Zheng, Dexuan, et al.
Publicado: (2018)

Metadherin regulates epithelial–mesenchymal transition in carcinoma
por: Wang, Zhao, et al.
Publicado: (2016)

Epithelial-Mesenchymal Transition: A Potential Therapeutic Goal for Prevention of Wound Fibrosis?
por: Farahani, Ramin Mostofi Zadeh
Publicado: (2006)

Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma
por: Hinton, Kristin, et al.
Publicado: (2023)

Osteopontin Splicing Isoforms Contribute to Endometriotic Proliferation, Migration, and Epithelial-Mesenchymal Transition in Endometrial Epithelial Cells
por: Ho, Nguyen-Tuong, et al.
Publicado: (2022)

Arabidopsis ACINUS is O-glycosylated and regulates transcription and alternative splicing of regulators of reproductive transitions
por: Bi, Yang, et al.
Publicado: (2021)

Regulation of Epithelial-to-Mesenchymal Transition by Alternative Translation Initiation Mechanisms and Its Implications for Cancer Metastasis
por: Bera, Amit, et al.
Publicado: (2020)

Epithelial-mesenchymal transition: potential regulator of ABC transporters in tumor progression
por: Jiang, Zong-Sheng, et al.
Publicado: (2017)

Regulation of epithelial-mesenchymal transition by protein lysine acetylation
por: Kong, Fanyun, et al.
Publicado: (2022)

Novel clinical therapeutics targeting the epithelial to mesenchymal transition
por: Kothari, Anai N, et al.
Publicado: (2014)

Epithelial–Mesenchymal Transition-Mediated Tumor Therapeutic Resistance
por: Xu, Zhimin, et al.
Publicado: (2022)

Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer
por: Fici, Pietro, et al.
Publicado: (2016)

Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools
por: Martínez-Montiel, Nancy, et al.
Publicado: (2017)

Alternative RNA splicing: contribution to pain and potential therapeutic strategy
por: Donaldson, Lucy F., et al.
Publicado: (2016)

Commentary: HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition
por: Baranwal, Somesh
Publicado: (2017)

Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts
por: Hernandez, James R., et al.
Publicado: (2015)

Role of Ferroptosis in Regulating the Epithelial–Mesenchymal Transition in Pulmonary Fibrosis
por: Ling, Hong, et al.
Publicado: (2023)

Alternative Splicing: A New Therapeutic Target for Ovarian Cancer
por: Yao, Shijie, et al.
Publicado: (2022)

Regulators of epithelial mesenchymal transition in pancreatic cancer
por: Hamada, Shin, et al.
Publicado: (2012)

MicroRNA Regulation of Epithelial to Mesenchymal Transition
por: Abba, Mohammed L., et al.
Publicado: (2016)

Exosomes Regulate the Epithelial–Mesenchymal Transition in Cancer
por: Jiang, Jingwen, et al.
Publicado: (2022)

Diverse alternative back-splicing and alternative splicing landscape of circular RNAs
por: Zhang, Xiao-Ou, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bt92hth76ath44r3j6sfve19j1